Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Relaxane claims supported – NAD

This article was originally published in The Tan Sheet

Executive Summary

Indigene Pharmaceuticals was able to support claims that its dietary supplement Relaxane relieves stress symptoms, the National Advertising Division concludes Dec 20. NAD evaluated three claims, including one that the product "is designed to provide stress relief and address multiple symptoms of stress." In support of its claims, the firm presented three clinical studies as well as two post-marketing surveys. NAD concluded it was "satisfied that the challenged advertising clearly conveys that Relaxane is for, and has been tested for, relief and alleviation of the symptoms associated with stress"...





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts